Search research articles
Contact Us
Filters
Showing results (251-260 of 545) with videos related to
Page
of 55
Sort By:
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
July 1, 1987
ATP-binding properties of P glycoprotein from multidrug-resistant KB cells
M M Cornwell, T Tsuruo, M M Gottesman, et al.
Cytotechnology
|
November 13, 2008
Apoptosis resistance in tumor cells
T Mashima, H Seimiya, Z Chen, et al.
Journal of Cellular Physiology
|
May 8, 1998
Suppression of interleukin-11-mediated bone resorption by cyclooxygenases inhibitors
Y Morinaga, N Fujita, K Ohishi, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1980
Inhibition of murine colon adenocarcinomas and Lewis lung carcinoma by 1-hexylcarbamoyl-5-fluorouracil
T Tsuruo, H Iida, K Naganuma, et al.
Leukemia Research
|
January 1, 1983
Effects of inducers of erythroid differentiation of human leukemia K562 cells on vincristine-resistant K562/VCR cells
J Okabe-Kado, M Hayashi, Y Honma, et al.
Acta Oncologica (Stockholm, Sweden)
|
January 1, 1995
Comparative study on reversal efficacy of SDZ PSC 833, cyclosporin A and verapamil on multidrug resistance in vitro and in vivo
T Watanabe, H Tsuge, T Oh-Hara, et al.
Cancer Research
|
May 15, 1991
Inhibition by erythroid differentiation factor (activin A) of P-glycoprotein expression in multidrug-resistant human K562 erythroleukemia cells
J Okabe-Kado, M Hayashi, Y Honma, et al.
Hepato-Gastroenterology
|
February 10, 1999
Dihydropyrimidine dehydrogenase but not thymidylate synthase expression is associated with resistance to 5-fluorouracil in colorectal cancer
M E Nita, O Tominaga, H Nagawa, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1992
Reversal of multidrug resistance by an immunosuppressive agent FK-506
M Naito, T Oh-hara, A Yamazaki, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research
|
April 1, 1995
Apoptosis inhibition by anti-M(r) 23,000 (Thy-1) monoclonal antibodies without inducing bcl-2 expression
N Fujita, M Naito, S H Lee, et al.
Page
of 55
Search research articles
Search
Showing results (251-260 of 545) with videos related to
Sort By:
Page
of 55
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
July 1, 1987
ATP-binding properties of P glycoprotein from multidrug-resistant KB cells
M M Cornwell, T Tsuruo, M M Gottesman, et al.
Cytotechnology
|
November 13, 2008
Apoptosis resistance in tumor cells
T Mashima, H Seimiya, Z Chen, et al.
Journal of Cellular Physiology
|
May 8, 1998
Suppression of interleukin-11-mediated bone resorption by cyclooxygenases inhibitors
Y Morinaga, N Fujita, K Ohishi, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1980
Inhibition of murine colon adenocarcinomas and Lewis lung carcinoma by 1-hexylcarbamoyl-5-fluorouracil
T Tsuruo, H Iida, K Naganuma, et al.
Leukemia Research
|
January 1, 1983
Effects of inducers of erythroid differentiation of human leukemia K562 cells on vincristine-resistant K562/VCR cells
J Okabe-Kado, M Hayashi, Y Honma, et al.
Acta Oncologica (Stockholm, Sweden)
|
January 1, 1995
Comparative study on reversal efficacy of SDZ PSC 833, cyclosporin A and verapamil on multidrug resistance in vitro and in vivo
T Watanabe, H Tsuge, T Oh-Hara, et al.
Cancer Research
|
May 15, 1991
Inhibition by erythroid differentiation factor (activin A) of P-glycoprotein expression in multidrug-resistant human K562 erythroleukemia cells
J Okabe-Kado, M Hayashi, Y Honma, et al.
Hepato-Gastroenterology
|
February 10, 1999
Dihydropyrimidine dehydrogenase but not thymidylate synthase expression is associated with resistance to 5-fluorouracil in colorectal cancer
M E Nita, O Tominaga, H Nagawa, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1992
Reversal of multidrug resistance by an immunosuppressive agent FK-506
M Naito, T Oh-hara, A Yamazaki, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research
|
April 1, 1995
Apoptosis inhibition by anti-M(r) 23,000 (Thy-1) monoclonal antibodies without inducing bcl-2 expression
N Fujita, M Naito, S H Lee, et al.
Page
of 55